 |
| Radiotherapy Market |
The global Radiotherapy Market is estimated to be valued at US$ 7560.28 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Radiotherapy uses high-energy radiation to treat cancer and tumors. It works by
damaging the DNA of cancer cells to stop their growth and division. The major
types of radiotherapy techniques used are external beam radiotherapy, internal
radiotherapy, and systemic radiotherapy.
Market key trends:
One of the key trends in the radiotherapy market is the rise of proton therapy.
Proton therapy is a type of external beam radiotherapy that uses protons rather
than X-rays to irradiate tumor tissues. Proton therapy delivers minimal
radiation to surrounding healthy tissues. This provides dosimetric advantages
over photon therapies for certain deep-seated tumors or those located near
vital organs. Proton therapy is also being explored as an alternative to
conventional radiotherapy for head and neck cancers, pediatric cancers, and
central nervous system tumors. The growing development of proton therapy
centers and the increasing clinical evidence highlighting the benefits of
proton therapy over photon therapy are expected to drive the adoption of proton
therapy in the coming years.
Segment Analysis
The global radiotherapy market is segmented by type, application, end user, and
region. Based on type, the external beam radiotherapy segment dominated the
market in 2022, accounting for around 76.5% share of the global market.
External beam radiotherapy offers advantages over other types such as faster
treatment, precise targeting, and lesser side effects.
Key Takeaways
The global Radiotherapy
Market Share is expected to witness high growth, exhibiting CAGR of 6.8% over the forecast period,
due to increasing prevalence of cancer cases globally.
Regional analysis
North America dominated the global market in 2022 and is expected to maintain
its dominance over the forecast period. This is attributed to the rising
geriatric population, increasing incidence of cancer, and growing acceptance of
radiotherapy.
Key players
Key players operating in the radiotherapy market are Accuray Incorporated,
Elekta, Isoray Inc., CIVCO, Hitachi, Ltd., Mevion Medical Systems, ProTom
International, VIEWRAY TECHNOLOGIES, INC., Panacea Medical Technologies Pvt.
Ltd., Optivus Proton Therapy, Inc., RefleXion, MacroMedics, Vision RT Ltd., and
Qfix.
Read More,
0 Comments